Home
India
Opinion
Karnataka
World
Business
Sports
Entertainment
Video
DH Specials
News Shots
Explainers
Bengaluru
Science
Trending
Brandspot
Photos
#DHCup2023
LATEST
E-PAPER
LATEST
E-PAPER
Home
India
Opinion
Karnataka
World
Business
Sports
Entertainment
Video
DH Specials
News Shots
Explainers
Bengaluru
Science
Trending
Brandspot
Photos
#DHCup2023
Home
News Shots
Trending
Menu
ADVERTISEMENT
BioNTech
EU authorises use of adapted Pfizer/BioNtech vaccine for Covid-19 variant
The European Medicines Authority (EMA) and the European Centre for Disease Prevention and Control recommend a single dose irrespective of vaccination history.
01 September 2023, 09:02 IST
EU authorises use of adapted Pfizer/BioNtech vaccine for Covid-19 variant
01 September 2023, 09:02 IST
BioNTech reduces drug development spend as Covid shot sales plunge
Second-quarter revenue dropped to €167.7 million ($184 million) from €3.2 billion a year earlier, as write-offs on Pfizer's assets ate into profit share payments.
07 August 2023, 14:08 IST
BioNTech reduces drug development spend as Covid shot sales plunge
07 August 2023, 14:08 IST
BioNTech ships 11,500 doses of Covid vaccine to China
The vaccines are expected to be available in Beijing, Shanghai, Guangzhou, Shenyang and Chengdu, BioNTech said
22 December 2022, 13:16 IST
BioNTech ships 11,500 doses of Covid vaccine to China
22 December 2022, 13:16 IST
Pfizer-BioNTech to test combined Covid-influenza jab
The combined vaccine is set to begin trials in the United States
03 November 2022, 14:36 IST
Pfizer-BioNTech to test combined Covid-influenza jab
03 November 2022, 14:36 IST
BioNTech develops method to detect high-risk variants
BioNTech and its partner said the new computational method can analyse genetic sequencing data of new coronavirus mutations
11 January 2022, 13:50 IST
BioNTech develops method to detect high-risk variants
11 January 2022, 13:50 IST
Pfizer and BioNTech to develop mRNA-based shingles jab
05 January 2022, 15:21 IST
Pfizer and BioNTech to develop mRNA-based shingles jab
05 January 2022, 15:21 IST
Possible to adapt jab quickly for Omicron: BioNTech CEO
Sahin also said that vaccines should continue to provide protection against severe disease, despite mutations
03 December 2021, 13:51 IST
Possible to adapt jab quickly for Omicron: BioNTech CEO
03 December 2021, 13:51 IST
Research finds Covid infection risk rises after second vaccine dose
29 November 2021, 06:18 IST
Research finds Covid infection risk rises after second vaccine dose
29 November 2021, 06:18 IST
BioNTech to seek approval for vaccine for 5-11-yr-olds
It has also laid out plans to seek approval in children aged 6 months to 2 years later this year
10 September 2021, 11:09 IST
BioNTech to seek approval for vaccine for 5-11-yr-olds
10 September 2021, 11:09 IST
BioNTech eye Rwanda, Senegal for malaria jab production
The future malaria and tuberculosis vaccines would be based on the so-called messenger RNA technology
27 August 2021, 14:51 IST
BioNTech eye Rwanda, Senegal for malaria jab production
27 August 2021, 14:51 IST
<
1
2
...
12
>